Sungyang Jo, MD; Ye-Jee Kim, PhD; Kye Won Park, MD; et al.
free access
has audio
JAMA Neurol. 2021;78(7):800-808. doi:10.1001/jamaneurol.2021.1335
This cohort study investigates the potential association between exposure to particulate matters (PM2.5 and PM10), nitrogen dioxide (NO2), ozone (O3), sulfur dioxide (SO2), and carbon monoxide (CO) and the risk of incident Parkinson disease.
-
Podcast:
Association of NO
2 and Other Air Pollution Exposures With the Risk of Parkinson Disease
Santosh B. Murthy, MD, MPH; Cenai Zhang, MS; Ivan Diaz, PhD; et al.
free access
JAMA Neurol. 2021;78(7):809-816. doi:10.1001/jamaneurol.2021.0925
This analysis of pooled cohort data from 4 popluation-based cohort studies evaluates whether intracerebral hemorrhage was associated with an increased risk of incident ischemic stroke and myocardial infarction.
Hannah C. Glass, MDCM, MAS; Janet S. Soul, MDCM; Taeun Chang, MD; et al.
open access
JAMA Neurol. 2021;78(7):817-825. doi:10.1001/jamaneurol.2021.1437
This comparative effectiveness study assesses whether discontinuation of antiseizure medication prior to discharge from the hospital after resolution of acute symptomatic neonatal seizures is associated with impaired functional neurodevelopment or the risk of epilepsy at 24 months.
Valeria Guglielmi, MD; Kars C. J. Compagne, MD; Amir Hossein Sarrami, MD; et al.
free access
JAMA Neurol. 2021;78(7):826-833. doi:10.1001/jamaneurol.2021.1101
This cohort study assesses the recurrent stroke risk in a population of patients with a large vessel occlusion stroke of the anterior circulation and ipsilateral carotid web.
Jerry R. Mendell, MD; Samiah A. Al-Zaidy, MD; Kelly J. Lehman, MSN; et al.
open access
JAMA Neurol. 2021;78(7):834-841. doi:10.1001/jamaneurol.2021.1272
This ongoing follow-up study of the START phase 1 clinical trial assesses the long-term safety and efficacy of onasemnogene abeparvovec in infants with spinal muscular atrophy type 1.
Alexander U. Brandt, MD; Michael Sy, MD, PhD; Judith Bellmann-Strobl, MD; et al.
open access
JAMA Neurol. 2021;78(7):842-852. doi:10.1001/jamaneurol.2021.1116
This cross-sectional study investigates a marker of endogenous serum N-acetylglucosamine levels in patients with multiple sclerosis (MS).
Theerawat Kumutpongpanich, MD; Masashi Ogasawara, MD; Ayami Ozaki, MD; et al.
free access
JAMA Neurol. 2021;78(7):853-863. doi:10.1001/jamaneurol.2021.1509
This case series identifies and characterizes the clinicopathologic features of patients with oculopharyngodistal myopathy with CGG repeat expansion in LRP12.